Seegene, Inc.
096530.KQ·KOSDAQ·Healthcare
31,800.00+300.00 (+0.95%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close31,500.00
Open32,050.00
Day range31,450.0032,950.00
52-week range21,700.0040,450.00
Off day high−3.49%
Off 52-week high−21.38%
Volume227.87K
Avg. volume (3M)328.99K
Market cap1.45T
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield3.81% (1,200.00)
Beta (5Y)0.90
Shares outstanding45.56M
Short interest—
Earnings dateNov 6, 2026
Analyst target48,000.00
Profit margin18.01%
Against its peers
Compare in full ›| 096530.KQ | 340450.KQ | 002030.SZ | TECH | 600645.SS | 301080.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 1.45T | 182.35B | 7.56B | 11.42B | 8.36B | 16.17B |
| P/E (TTM) | — | — | — | 62.7 | 74.4 | 83.1 |
| Forward P/E | — | — | 24.5 | 31.5 | 40.6 | — |
| Price/book | — | — | 1.1 | 5.4 | 2.1 | 5.9 |
| Dividend yield | 3.81% | — | — | 0.44% | — | 0.63% |
| 1-year change | +20.46% | +14.35% | −18.97% | +25.01% | −29.27% | +56.35% |
| Today | +0.95% | −3.26% | +0.94% | +0.10% | +1.94% | +1.77% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 096530.KQ news ›Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
Jul 21, 2026, 09:00 ET In a poster presented at the 2024 Clinical Virology Symposium[5], scientists evaluated samples that had previously tested negative using single-pathogen methods and found that a multiplex PCR assay identified HSV,…
From the 4Search news index, newest first.